Schedule 13G ownership disclosure
IMMUNOCORE HOLDINGS PLC
ADR · CUSIP: 45258D105
Event date: 2026-02-28
- Filing-level shares
- 3,041,904
- Percent of class
- 6.0%
- T. Rowe Price Investment Management, Inc.
Shares: 3,041,904 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-26-000309
- Form type
- SCHEDULE 13G/A
- Filer
- Immunocore Holdings plc
- CIK
- CIK 1671927
- Filed
- Mar 06, 2026
- Reporting period
- Feb 28, 2026
- Description
- Schedule 13G beneficial ownership